MassMutual Private Wealth & Trust FSB Buys 106,709 Shares of Cardinal Health, Inc. $CAH

Key Points

• MassMutual Private Wealth & Trust FSB increased its Cardinal Health stake by 6,447.7% in the third quarter, buying 106,709 additional shares and bringing its holdings to 108,364 shares valued at approximately $24.1 million.
• Cardinal Health reported quarterly EPS of $2.91, exceeding the $2.42 analyst consensus, while revenue rose 5.8% year over year to $63.67 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $266.56.
• The company extended its CVS Health distribution agreement through 2032 and reaffirmed fiscal 2027 adjusted EPS guidance of $12.40–$12.60; however, insiders have sold substantial shares recently, with no reported insider purchases.

MassMutual Private Wealth & Trust FSB increased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 6,447.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 108,364 shares of the company's stock after purchasing an additional 106,709 shares during the period. MassMutual Private Wealth & Trust FSB's holdings in Cardinal Health were worth $24,111,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in CAH. BlackRock Inc. acquired a new position in shares of Cardinal Health during the second quarter valued at $6,293,115,000. Wellington Management Group LLP increased its holdings in shares of Cardinal Health by 247.5% in the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company's stock worth $3,530,206,000 after acquiring an additional 10,584,119 shares during the period. Bank of America Corp DE bought a new stake in Cardinal Health in the 2nd quarter valued at about $689,066,000. Victory Capital Management Inc. lifted its position in Cardinal Health by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,698,189 shares of the company's stock valued at $554,478,000 after purchasing an additional 414,074 shares during the last quarter. Finally, Legal & General Group Plc acquired a new position in Cardinal Health during the 2nd quarter valued at about $438,870,000. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a "neutral" rating in a research report on Thursday, August 13th. Zacks Research cut Cardinal Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, June 12th. TD Cowen lifted their target price on Cardinal Health from $275.00 to $280.00 and gave the company a "buy" rating in a research note on Thursday, August 13th. Weiss Ratings cut Cardinal Health from a "buy (b+)" rating to a "buy (b)" rating in a research note on Wednesday, August 19th. Finally, Evercore reissued an "outperform" rating and set a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $266.56.

Cardinal Health Trading Up 0.2%

Shares of CAH stock opened at $228.78 on Monday. The firm's fifty day simple moving average is $233.02 and its 200 day simple moving average is $220.11. The firm has a market capitalization of $52.98 billion, a P/E ratio of 31.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.50. Cardinal Health, Inc. has a 1 year low of $150.77 and a 1 year high of $258.30.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts' consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the business earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities research analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. Cardinal Health's payout ratio is presently 28.49%.

Insider Buying and Selling

In related news, CAO Mary C. Scherer sold 2,302 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total transaction of $546,471.78. Following the completion of the transaction, the chief accounting officer owned 2,811 shares in the company, valued at $667,303.29. This trade represents a 45.02% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica Mayer sold 29,436 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company's stock, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 210,271 shares of company stock worth $49,626,657. Insiders own 0.12% of the company's stock.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health signed a binding letter of intent to continue its existing distribution services for CVS Health through 2032. The extension provides longer-term revenue visibility without requiring a change to the current scope of services. Cardinal Health CVS distribution agreement
• Positive Sentiment: CVS Health was identified as Cardinal Health’s only customer representing at least 10% of fiscal 2026 revenue or gross trade receivables, making the renewal particularly important for protecting future sales and earnings visibility. Cardinal Health CVS deal and outlook
• Positive Sentiment: Management reaffirmed fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, broadly in line with the approximately $12.56 analyst consensus, as well as its long-term adjusted EPS growth target of 12% to 14%. The absence of a guidance cut supports confidence in the outlook. Cardinal Health and McKesson CVS agreements
• Neutral Sentiment: Cardinal Health plans to report fiscal 2027 first-quarter results before the market opens on November 5, giving investors a forthcoming catalyst to assess prescription volumes, margins and the impact of the renewed CVS relationship. Cardinal Health first-quarter earnings date
• Negative Sentiment: Separate tracking data shows substantial insider selling over the past six months, with no reported insider purchases. While these transactions may reflect planned diversification rather than a change in fundamentals, they could temper enthusiasm around the shares.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.